The Optimization of Procedural Pain Control in Intensive Care Unit (ICU) Patients
NCT ID: NCT00558090
Last Updated: 2010-03-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
150 participants
INTERVENTIONAL
2008-02-29
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketorolac at Lower Doses for Analgesic Pain Control in ICU: A Pilot Feasibility Study
NCT06819956
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
NCT02299024
Reduced Opioid Analgesic Requirements Via Improved Endogenous Opioid Function
NCT02469077
Effect of Early Pain Management at Triage on Opioid Consumption
NCT03243006
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
NCT01167127
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
patients receive 2,5 mg morphine iv, before the first intervention on the day after admission in the ICU
morphine
patients receive 7,5 mg morphine iv 30 minutes before intervention (turning of the patient), the day after admission in the ICU. before, during and after, the patient will be asked to rate the pain using the NRS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
morphine
patients receive 7,5 mg morphine iv 30 minutes before intervention (turning of the patient), the day after admission in the ICU. before, during and after, the patient will be asked to rate the pain using the NRS
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Language barrier
* Known morphine iv allergy
* Comatose patients (cooled)
* Patients who are suspected to be brain-dead
* Unintubated patients on the verge of intubation due to respiratory insufficiency
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erasmus Medical Center
OTHER
St. Antonius Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
St Antonius Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherijne AJ Knibbe, Pharm D
Role: PRINCIPAL_INVESTIGATOR
St Antonius Hospital, Department of Clinical Pharmacy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St antonius Hospital
Nieuwegein, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Goulooze SC, Krekels EH, Saleh MA, Ahlers SJ, Valitalo PA, van Dongen EP, van Schaik RH, Hankemeier T, Tibboel D, Knibbe CAJ. Predicting Unacceptable Pain in Cardiac Surgery Patients Receiving Morphine Maintenance and Rescue Doses: A Model-Based Pharmacokinetic-Pharmacodynamic Analysis. Anesth Analg. 2021 Mar 1;132(3):726-734. doi: 10.1213/ANE.0000000000005228.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL18828.100.07
Identifier Type: -
Identifier Source: secondary_id
R-07.15A/OPCIC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.